Form 4: NeonC Technologies Director Ming-Fu (Alan) Chiang Reports Share Transactions

Director Ming-Fu (Alan) Chiang reports acquisition and disposal of NeonC Technologies Holdings, Inc. shares, including a grant of restricted stock and a transfer of shares held by HCWG LLC.

Summary

• On March 26, 2025, Ming-Fu (Alan) Chiang, a director of NeonC Technologies Holdings, Inc., reported transactions involving the company's common stock.
• Chiang acquired 50,000 shares of restricted common stock as a grant under the company's 2023 Equity Incentive Plan, vesting seven months after the initial listing date.
• Chiang also reported the disposal of 5,994 shares of common stock held by HCWG LLC, based on a per share value of $18.
• Following these transactions, Chiang directly owns 390,216 shares and indirectly owns shares through HCWG LLC (324,688), Orion Biomed Inc. (29,309), and NeuCen Biomedical Co. Ltd. (888,148).
• Chiang disclaims beneficial ownership of shares held by Orion Biomed Inc., NeuCen Biomedical Co. Ltd., and certain family members, except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. The sentiment is neutral as it primarily reports facts without expressing opinions or forecasts.

Positives

• The grant of 50,000 restricted shares to a director suggests an alignment of interests with shareholders and incentivizes future performance.

Negatives

• The disposal of 5,994 shares, even if through a controlled entity, could be perceived negatively by investors.

Risks

• The disclaimer of beneficial ownership of shares held by related entities introduces complexity in assessing the director's overall stake and influence.

Future Outlook

The vesting of the restricted stock is contingent upon the effective date of the Issuer's initial listing, suggesting an expectation of a future listing event.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, allowing investors to monitor potential shifts in ownership and sentiment.

Related Party Transactions

• Transactions involving HCWG LLC, Orion Biomed Inc., and NeuCen Biomedical Co. Ltd., entities with connections to the reporting person, are disclosed as related party transactions.

Stakeholder Impact

• The reported transactions provide shareholders with insights into the director's holdings and potential alignment with their interests.

Key Dates

Keywords

Form 4, beneficial ownership, NTHI, NeonC Technologies, director, Ming-Fu Chiang, stock transaction, restricted stock, HCWG LLC, Orion Biomed, NeuCen Biomedical